A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis

Mikio Kajihara, Shinzo Kato, Yuka Okazaki, Yutaka Kawakami, Hiromasa Ishii, Yasuo Ikeda, Masataka Kuwana

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Thrombocytopenia is a common manifestation in patients with liver cirrhosis (LC), but its underlying mechanism remains controversial. This study examined the role of anti-platelet autoimmunity in cirrhotic thrombocytopenia by determining the autoantibody response to GPIIb-IIIa, a major platelet surface autoantigen recognized by anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP). Circulating B cells producing anti-GPIIb-IIIa antibodies as well as platelet-associated and plasma anti-GPIIb-IIIa antibodies were examined in 72 patients with LC, 62 patients with ITP, and 52 healthy controls. In vitro anti-GPIIb-IIIa antibody production was induced in cultures of peripheral blood mononuclear cells (PBMCs) by stimulation with GPIIb-IIIa. The frequency of anti-GPIIb-IIIa antibody-producing B cells in patients with LC was significantly greater than in healthy controls (10.9 ± 6.2 vs. 0.4 ± 0.3/105 PBMCs; P < .0001) and was even higher than the frequency in patients with ITP (8.2 ± 5.2; P = .007). Anti-GPIIb-IIIa antibodies in the patients with LC and ITP were mainly present on the surfaces of circulating platelets rather than in the plasma in an unbound form. Furthermore, PBMCs from patients with LC and ITP produced anti-GPIIb-IIIa antibodies on antigenic stimulation with GPIIb-IIIa in vitro, and the specific antibodies produced had the capacity to bind normal platelet surfaces. In conclusion, the similar profile of the anti-GPIIb-IIIa autoantibody response in patients with LC and ITP suggests that autoantibody-mediated platelet destruction may contribute at least in part to cirrhotic thrombocytopenia.

Original languageEnglish
Pages (from-to)1267-1276
Number of pages10
JournalHepatology
Volume37
Issue number6
DOIs
Publication statusPublished - 2003 Jun 1

Fingerprint

Thrombocytopenia
Autoantibodies
Fibrosis
Idiopathic Thrombocytopenic Purpura
Blood Platelets
Liver Cirrhosis
Antibodies
Blood Cells
B-Lymphocytes
Antibody-Producing Cells
Autoantigens
Autoimmunity
Antibody Formation
Anti-Idiotypic Antibodies

ASJC Scopus subject areas

  • Hepatology

Cite this

Kajihara, M., Kato, S., Okazaki, Y., Kawakami, Y., Ishii, H., Ikeda, Y., & Kuwana, M. (2003). A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatology, 37(6), 1267-1276. https://doi.org/10.1053/jhep.2003.50209

A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. / Kajihara, Mikio; Kato, Shinzo; Okazaki, Yuka; Kawakami, Yutaka; Ishii, Hiromasa; Ikeda, Yasuo; Kuwana, Masataka.

In: Hepatology, Vol. 37, No. 6, 01.06.2003, p. 1267-1276.

Research output: Contribution to journalArticle

Kajihara, M, Kato, S, Okazaki, Y, Kawakami, Y, Ishii, H, Ikeda, Y & Kuwana, M 2003, 'A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis', Hepatology, vol. 37, no. 6, pp. 1267-1276. https://doi.org/10.1053/jhep.2003.50209
Kajihara, Mikio ; Kato, Shinzo ; Okazaki, Yuka ; Kawakami, Yutaka ; Ishii, Hiromasa ; Ikeda, Yasuo ; Kuwana, Masataka. / A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. In: Hepatology. 2003 ; Vol. 37, No. 6. pp. 1267-1276.
@article{72d869ad37d94e9eab6826d59bc2bb4c,
title = "A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis",
abstract = "Thrombocytopenia is a common manifestation in patients with liver cirrhosis (LC), but its underlying mechanism remains controversial. This study examined the role of anti-platelet autoimmunity in cirrhotic thrombocytopenia by determining the autoantibody response to GPIIb-IIIa, a major platelet surface autoantigen recognized by anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP). Circulating B cells producing anti-GPIIb-IIIa antibodies as well as platelet-associated and plasma anti-GPIIb-IIIa antibodies were examined in 72 patients with LC, 62 patients with ITP, and 52 healthy controls. In vitro anti-GPIIb-IIIa antibody production was induced in cultures of peripheral blood mononuclear cells (PBMCs) by stimulation with GPIIb-IIIa. The frequency of anti-GPIIb-IIIa antibody-producing B cells in patients with LC was significantly greater than in healthy controls (10.9 ± 6.2 vs. 0.4 ± 0.3/105 PBMCs; P < .0001) and was even higher than the frequency in patients with ITP (8.2 ± 5.2; P = .007). Anti-GPIIb-IIIa antibodies in the patients with LC and ITP were mainly present on the surfaces of circulating platelets rather than in the plasma in an unbound form. Furthermore, PBMCs from patients with LC and ITP produced anti-GPIIb-IIIa antibodies on antigenic stimulation with GPIIb-IIIa in vitro, and the specific antibodies produced had the capacity to bind normal platelet surfaces. In conclusion, the similar profile of the anti-GPIIb-IIIa autoantibody response in patients with LC and ITP suggests that autoantibody-mediated platelet destruction may contribute at least in part to cirrhotic thrombocytopenia.",
author = "Mikio Kajihara and Shinzo Kato and Yuka Okazaki and Yutaka Kawakami and Hiromasa Ishii and Yasuo Ikeda and Masataka Kuwana",
year = "2003",
month = "6",
day = "1",
doi = "10.1053/jhep.2003.50209",
language = "English",
volume = "37",
pages = "1267--1276",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis

AU - Kajihara, Mikio

AU - Kato, Shinzo

AU - Okazaki, Yuka

AU - Kawakami, Yutaka

AU - Ishii, Hiromasa

AU - Ikeda, Yasuo

AU - Kuwana, Masataka

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Thrombocytopenia is a common manifestation in patients with liver cirrhosis (LC), but its underlying mechanism remains controversial. This study examined the role of anti-platelet autoimmunity in cirrhotic thrombocytopenia by determining the autoantibody response to GPIIb-IIIa, a major platelet surface autoantigen recognized by anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP). Circulating B cells producing anti-GPIIb-IIIa antibodies as well as platelet-associated and plasma anti-GPIIb-IIIa antibodies were examined in 72 patients with LC, 62 patients with ITP, and 52 healthy controls. In vitro anti-GPIIb-IIIa antibody production was induced in cultures of peripheral blood mononuclear cells (PBMCs) by stimulation with GPIIb-IIIa. The frequency of anti-GPIIb-IIIa antibody-producing B cells in patients with LC was significantly greater than in healthy controls (10.9 ± 6.2 vs. 0.4 ± 0.3/105 PBMCs; P < .0001) and was even higher than the frequency in patients with ITP (8.2 ± 5.2; P = .007). Anti-GPIIb-IIIa antibodies in the patients with LC and ITP were mainly present on the surfaces of circulating platelets rather than in the plasma in an unbound form. Furthermore, PBMCs from patients with LC and ITP produced anti-GPIIb-IIIa antibodies on antigenic stimulation with GPIIb-IIIa in vitro, and the specific antibodies produced had the capacity to bind normal platelet surfaces. In conclusion, the similar profile of the anti-GPIIb-IIIa autoantibody response in patients with LC and ITP suggests that autoantibody-mediated platelet destruction may contribute at least in part to cirrhotic thrombocytopenia.

AB - Thrombocytopenia is a common manifestation in patients with liver cirrhosis (LC), but its underlying mechanism remains controversial. This study examined the role of anti-platelet autoimmunity in cirrhotic thrombocytopenia by determining the autoantibody response to GPIIb-IIIa, a major platelet surface autoantigen recognized by anti-platelet antibodies in patients with idiopathic thrombocytopenic purpura (ITP). Circulating B cells producing anti-GPIIb-IIIa antibodies as well as platelet-associated and plasma anti-GPIIb-IIIa antibodies were examined in 72 patients with LC, 62 patients with ITP, and 52 healthy controls. In vitro anti-GPIIb-IIIa antibody production was induced in cultures of peripheral blood mononuclear cells (PBMCs) by stimulation with GPIIb-IIIa. The frequency of anti-GPIIb-IIIa antibody-producing B cells in patients with LC was significantly greater than in healthy controls (10.9 ± 6.2 vs. 0.4 ± 0.3/105 PBMCs; P < .0001) and was even higher than the frequency in patients with ITP (8.2 ± 5.2; P = .007). Anti-GPIIb-IIIa antibodies in the patients with LC and ITP were mainly present on the surfaces of circulating platelets rather than in the plasma in an unbound form. Furthermore, PBMCs from patients with LC and ITP produced anti-GPIIb-IIIa antibodies on antigenic stimulation with GPIIb-IIIa in vitro, and the specific antibodies produced had the capacity to bind normal platelet surfaces. In conclusion, the similar profile of the anti-GPIIb-IIIa autoantibody response in patients with LC and ITP suggests that autoantibody-mediated platelet destruction may contribute at least in part to cirrhotic thrombocytopenia.

UR - http://www.scopus.com/inward/record.url?scp=0038241772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038241772&partnerID=8YFLogxK

U2 - 10.1053/jhep.2003.50209

DO - 10.1053/jhep.2003.50209

M3 - Article

C2 - 12774004

AN - SCOPUS:0038241772

VL - 37

SP - 1267

EP - 1276

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -